Heterocyclic hybrid frameworks represent a burgeoning
domain within
the realms of drug discovery and medicinal chemistry, attracting considerable
attention in recent years. Thiazole pharmacophore fragments, inherent
in natural products such as peptide alkaloids, metabolites, and cyclopeptides,
have demonstrated a broad spectrum of pharmacological potentials.
Given their profound biological significance, a plethora of thiazole-based
hybrids have been synthesized through the conjugation of thiazole
moieties with bioactive pyrazole and pyrazoline fragments. This review
systematically presents a compendium of robust methodologies for the
synthesis of thiazole-linked hybrids, employing the (3 + 2) heterocyclization
reaction, specifically the Hantzsch-thiazole synthesis, utilizing
phenacyl bromide as the substrate. The strategic approach of molecular
hybridization has markedly enhanced drug efficacy, mitigated resistance
to multiple drugs, and minimized toxicity concerns. The resultant
thiazole-linked hybrids exhibit a myriad of medicinal properties viz. anticancer, antibacterial, anticonvulsant, antifungal,
antiviral, and antioxidant activities. This compilation of methodologies
and insights serves as a valuable resource for medicinal chemists
and researchers engaged in the design of novel thiazole-linked hybrids
endowed with therapeutic attribute.